Drug profile · INN
monomethyl fumarate
BAFIERTAM
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
monomethyl fumarate (BAFIERTAM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN monomethyl fumarate
Brand BAFIERTAM
Route ORAL
Formulation CAPSULE, DELAYED RELEASE
Frequently asked questions
What is monomethyl fumarate?
monomethyl fumarate (BAFIERTAM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for monomethyl fumarate?
BAFIERTAM is a marketed brand name for monomethyl fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of monomethyl fumarate?
monomethyl fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.